Procurement Summary
Country : Ukraine
Summary : Ketorolak Solution for Injection, 30 Mg/Ml, 1 Ml, Amoxicillin and Clavulanic Acid, Injection Powder/Infusions 1.2 Grams, Benzylbenzoate Emulsion Emulsion, 200 Mg/G, 50 G in the Vial, Betagisin Tablets ...
Deadline : 11 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117412639
Document Ref. No. : UA-2025-04-08-009950-a
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : UAH 1160620
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Ketorolac solution for injection, 30 mg/ml, 1 ml, amoxicillin and clavulanoic acid, injection/infusions powder 1.2 gr, benzylbenzoate Emulsion Sickirne, 200 mg/g, 50 g in a vial, Betagisin of the tablet, dexpantine mg/g of 116 g, diphenhydramine, solution for injection, 10 mg/ml, 1 ml, doxazosin, tablets, 2 mg, etamzilate solution for injection, 125 mg/ml of 2 ml, anti-D human immunoglobulin, solution for injection, 300 mcg (1500 IU)/2 ml, 2 ml. tablets covered with film sheath, 20 mg, human insulin (medium duration), suspension for injection, 100 U/ml, vial, 5 ml, human insulin (short duration), solution for injection, 100 U/ml, vial, 5 ml, insulin (combination: 25% short duration);100 units/ml, cartridge, 3 ml, chlorhexidine, solution for external use of 0.05 % 200 ml, №1, iron hydroxide-storage complex, solution for injection, 20 mg/ml of 5 ml, rifampicin capsules of 150 mg, ulipil solution for injections, 5 ml.solution for injection, 20 mg/ml, 5 ml, oxybuprocaine droplets, 0.4 %solution, 10 ml in a container-droplet, norepinephrine, concentrate for infusion solution, 2 mg/ml 4 ml, phenylephrine drops ml, metoprolol tablets of 50 mg ...
speciesProcurement: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
ketorolac solution for injection, 30 mg/ml, 1 ml, amoxicillin and clavulanic acid, powder for injection/infusions 1.2 grams, benzylbenzoate Emulbenzoate. tablets of 16 mg, dexpanthenol ointment 5%30 g, dexpanthenol foam 50 mg/g of 116 g, diphenhydramine, solution for injection, 10 mg/ml, 1 ml, doxazosin, tablets, 2 mg, etamzilate solution for injection, 125 mg/ml 2 ml, anti-d/mlnniolobulin, for injection, anti-200 ml. ml, deketoprofen solution forinjections of 25 mg/ml 2 ml, rivoroxaban tablets covered with a film sheath, 20 mg, insulin of humans (medium duration), suspension for injection, 100 units/ml, vial, 5 ml, insulin (short duration of action), solution for injection, 100 Ul.25% short duration of action; 75 % of the average duration ...
Documents
Tender Notice